1. Home
  2. VANI vs OZKAP Comparison

VANI vs OZKAP Comparison

Compare VANI & OZKAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vivani Medical Inc. (DE)

VANI

Vivani Medical Inc. (DE)

HOLD

Current Price

$1.18

Market Cap

100.0M

Sector

Health Care

ML Signal

HOLD

Logo Bank OZK 4.625% Series A Non-Cumulative Perpetual Preferred Stock

OZKAP

Bank OZK 4.625% Series A Non-Cumulative Perpetual Preferred Stock

N/A

Current Price

$16.30

Market Cap

0.0

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
VANI
OZKAP
Founded
1998
N/A
Country
United States
United States
Employees
N/A
3280
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
100.0M
N/A
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
VANI
OZKAP
Price
$1.18
$16.30
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.50
N/A
AVG Volume (30 Days)
187.0K
20.9K
Earning Date
05-14-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.92
$15.69
52 Week High
$1.92
$17.85

Technical Indicators

Market Signals
Indicator
VANI
OZKAP
Relative Strength Index (RSI) 46.97 41.90
Support Level $1.15 $15.92
Resistance Level $1.26 $16.69
Average True Range (ATR) 0.07 0.15
MACD -0.01 -0.02
Stochastic Oscillator 26.13 20.73

Price Performance

Historical Comparison
VANI
OZKAP

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.

About OZKAP Bank OZK 4.625% Series A Non-Cumulative Perpetual Preferred Stock

Bank OZK is a bank holding company that owns and operates a community bank, Bank of the Ozarks. The bank operates offices in Arkansas, Georgia, Florida, North Carolina, Texas, California, New York and Mississippi. It provides banking services, including checking, savings, money market, time deposits, and individual retirement accounts, as well as loan services, such as real estate, consumer, commercial, and industrial loans. Apart from providing traditional banking products and services, it also provides trust and wealth management, financial planning, online banking, and other related services.

Share on Social Networks: